UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028500
Receipt number R000032616
Scientific Title Clinical trials on weight loss in obesity impaired glucose tolerance (IGT) patients and mild diabetic patients using FreeStyle Libre.
Date of disclosure of the study information 2018/04/10
Last modified on 2023/02/13 17:30:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trials on weight loss in obesity impaired glucose tolerance (IGT) patients and mild diabetic patients using FreeStyle libre.(Transitioned to jRCT)

Acronym

Clinical trials on weight loss in obesity impaired glucose tolerance (IGT) patients and mild diabetic patients using FreeStyle libre.

Scientific Title

Clinical trials on weight loss in obesity impaired glucose tolerance (IGT) patients and mild diabetic patients using FreeStyle Libre.

Scientific Title:Acronym

Clinical trials on weight loss in obesity impaired glucose tolerance (IGT) patients and mild diabetic patients using FreeStyle Libre.

Region

Japan


Condition

Condition

Obesity impaired glucose tolerance patient
Obese mild diabetic patient

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify whether visualization of blood glucose variability becomes an effective self-monitoring index for strengthening obesity behavioral therapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Weight loss amount during 6 months after intervention

Key secondary outcomes

Improvement of impaired glucose tolerance evaluated by 75gOGTT at 6 months after intervention, improvement of HbA1c, blood pressure, serum lipid, serum uric acid value, serum transaminase value, dietary intake, Change in quantity, change in health-related QOL, blood glucose fluctuation data, pruritus feeling of the attachment part of FreeStyle libre, frequency of eruption,lipid mediator values before and 6 months after intervention


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Place FreeStyle Libre for 6 months

Interventions/Control_2

Place FreeStyle Libre Pro for 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients who are over 20 years of age at consent acquisition
2)Patients who do not meet the diagnostic criteria of IGT at 75 g OGTT or who are not using oral hypoglycemic drugs with HbA 1 c below 7.0%
3)Sex is not an issue
4)Outpatient
5)With regard to participation in this study, patients who gained document consent by their own voluntary intention

Key exclusion criteria

1)Patients participating in other clinical trials
2)Patients with severe skin disease on the upper arm
3)Patients using other implantable medical devices such as pacemakers
4)In addition, patients judged inappropriate by the doctor in charge of this study
5)Patients who do not have dyslipidemia or hyperuricemia among patients with BMI of 25kg/m2 or more and less than 30kg/m 2 diagnosed with IGT

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yushi
Middle name
Last name Yushi

Organization

Kobe University Medical School Hospital

Division name

Diabetesï½¥Endocrine internal medicine

Zip code

650-0017

Address

7-5-2 Kusunokimachi, Chuo-ku, Kobe-shi Hyogo ken

TEL

078-382-5861

Email

hirota@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Yasushi
Middle name
Last name Nakagawa

Organization

Kobe University Graduate School of Medicine

Division name

Diabetes / Endocrine Internal Science

Zip code

650-0017

Address

7-5-2 Kusunokimachi, Chuo-ku, Kobe-shi Hyogo ken

TEL

078-382-5861

Homepage URL


Email

yasushi@med.kobe-u.ac.jp


Sponsor or person

Institute

kobe University Graduate School of Medicine Diabetes / Endocrine Internal Science

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Clinical Research Review Committee Secretariat

Address

7-5-2 Kusunokimachi, Chuo-ku, Kobe-shi Hyogo ken

Tel

078-382-6669

Email

cerb@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 01 Month 18 Day

Date of IRB

2018 Year 01 Month 18 Day

Anticipated trial start date

2018 Year 05 Month 31 Day

Last follow-up date

2022 Year 01 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Transitioned to jRCT, jRCTs052180079


Management information

Registered date

2017 Year 08 Month 02 Day

Last modified on

2023 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032616


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name